Metraipolis › archive › dc_324a5bfd3bc5

Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA — Europe PMC PMID:41608588

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41608588
DOI
10.7150/thno.122132
License (as archived)
solo-consultazione
Archived
2026-11-07T06:54:23.246Z
SHA-256 of the archived text
5b8b6ae5ac9000caec8c7dd8fecae2e0d71dd00f44f3abbc69bf16330bab09fd
Stable URL of this page
https://metraipolis.com/documento/dc_324a5bfd3bc5

How to cite

Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA — Europe PMC PMID:41608588 — Europe PMC (en), https://europepmc.org/article/MED/41608588 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_324a5bfd3bc5 (Metraipolis archive dc_324a5bfd3bc5, sha256 5b8b6ae5ac9000caec8c7dd8fecae2e0d71dd00f44f3abbc69bf16330bab09fd)
BibTeX
@misc{dc324a5bfd3bc5,
  title = {Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA — Europe PMC PMID:41608588},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41608588},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_324a5bfd3bc5; sha256 5b8b6ae5ac9000caec8c7dd8fecae2e0d71dd00f44f3abbc69bf16330bab09fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608588. Agents can read the archived copy with the MCP tool read_document.